Workflow
WSJ
icon
Search documents
When considered as a percentage of GDP, the 2026 projected AI-driven spending by Amazon, Alphabet, Microsoft and Meta rivals momentous capital efforts in U.S. history, as shown in these charts
WSJ· 2026-02-07 10:30
Core Insights - The projected spending of four major tech companies for 2026 is expected to be significant, comparable to historical capital efforts in the U.S. [1] Group 1 - The spending of these tech giants, when viewed as a percentage of GDP, indicates a substantial investment trend [1]
Heard on the Street: : The obesity-market price war has turned traditional pharma economics upside down.
WSJ· 2026-02-07 10:30
Core Insights - Prices for GLP-1 medications are experiencing a rapid decline, prompting companies to adjust their strategies to maintain profitability and market share [1] Industry Impact - The decrease in GLP-1 prices is attributed to increased competition and the introduction of generic alternatives, which is reshaping the market dynamics [1] - Companies are now focusing on cost management and innovation to counteract the pricing pressures [1] Company Strategies - Pharmaceutical companies are exploring new formulations and delivery methods for GLP-1s to differentiate their products in a crowded market [1] - There is a shift towards enhancing marketing efforts and patient engagement to retain customer loyalty despite falling prices [1]
A New Crypto Winter Is Here and Even the Biggest Bulls Are Worried
WSJ· 2026-02-07 02:00
Bitcoin just suffered its largest weekly decline in more than three years. But the worst part for some of crypto's permabulls is that they aren't sure what exactly caused the crash. ...
FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs
WSJ· 2026-02-06 23:23
Core Viewpoint - The FDA is taking decisive steps to restrict the use of GLP-1 active pharmaceutical ingredients in non-approved drugs [1] Group 1 - The FDA's actions indicate a regulatory tightening around GLP-1 drugs, which may impact companies involved in the development and marketing of these pharmaceuticals [1]
Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe
WSJ· 2026-02-06 19:30
As it probes bids for Warner, the department is asking if the streamer has engaged in conduct that could make it a monopoly. ...
Dow Jones Industrial Average Hits 50000 for First Time
WSJ· 2026-02-06 19:24
The blue-chip index's climb comes as the U.S. economy has muscled past its rich peers and snapped up investment the world over. ...
Opinion | Is President Trump Right About His Tariffs?
WSJ· 2026-02-06 16:56
This could be the start of a new golden age or a tax on the American Dream for average citizens. ...
Consumer Sentiment Has Climbed in February, per Michigan Survey
WSJ· 2026-02-06 15:47
Consumer sentiment ticked up to 57.3 in February, according to a preliminary reading from the University of Michigan's monthly survey, a positive signal that Americans' economic mood is improving despite longstanding anxieties about inflation and the job market. ...